1. Eminger LA, Hall LD, Hesterman KS, Heymann WR. Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors. J Am Acad Dermatol. 2015; 72:21–34.
2. Kim YJ, Choi SY, Lee WJ, Won CH, Chang SE, Choi JH, et al. Two cases of hydroa vacciniforme-like lymphoproliferative disease controlled by anti-inflammatory agents. Photodermatol Photoimmunol Photomed. 2017; 33:287–290.
Article
3. Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, et al. Clinicopathological categorization of Epstein-Barr viruspositive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Leuk Lymphoma. 2017; 58:53–63.
Article
4. Yang YQ, Fan L, Wang L, Xu J, Zhang R, Ge Z, et al. Systemic lymphoma arising from hydroa vacciniforme-like lymphoma: report of two cases with review of literature. Int J Clin Exp Pathol. 2014; 7:6403–6408.
5. Imadome K, Yajima M, Arai A, Nakazawa A, Kawano F, Ichikawa S, et al. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBVinfected T and NK cells. PLoS Pathog. 2011; 7:e1002326.
Article